Traitement des lymphomes de Hodgkin localisés
Reference60 articles.
1. Lister TA, Crowther D, Sutcliffe SB, et al. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7(11): 1630–6
2. Specht (1996) Prognostic Factors in Hodgkin’s Disease. Semin Radiat Oncol 6(3): 146–61
3. Tubiana M, Henry-Amar M, van der Werf-Messing B, et al. (1985) A multivariate analysis of prognostic factors in early stage Hodgkin’s disease. Int J Radiat Oncol Biol Phys 11(1): 23–30
4. Specht L, Raemaekers J (2007) Do we need an early unfavorable (intermediate) stage of Hodgkin’s lymphoma? Hematol Oncol Clin North Am 21(5): 881–96
5. Noordijk EM, Carde P, Dupouy N, et al. (2006) Combined-modality therapy for clinical stage I or II Hodgkin’s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol 24(19): 3128–35